StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$3.82−0.48 (-11.09%)

Close on Nov 18, 2026Market cap $3.83MP/E –Yield –

Shuttle Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Shuttle Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2023 was -$5.60M. For fiscal 2023 it was -$5.60M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$5.60M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$1.06M–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?